VeriMomIst cymbopogon citratus leaf extract oxidized in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
Related ingredients
Frequently asked questions
- Ist cymbopogon citratus leaf extract oxidized in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
- Ist cymbopogon citratus leaf extract oxidized während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity for this ingredient in authoritative assessments. Systemic transfer into breastmilk is theoretical but not demonstrated for this extract; exposure scored as low (1) given potential for low systemic absorption of volatile constituents with topical use. Sources: ECHA Annex VI, PubChem, CosIng, PubMed (no specific studies).
- Ist cymbopogon citratus leaf extract oxidized sicher für Babyhaut?
- No infant-specific toxicity data were found and no harmonised reproductive/ developmental classification applies. Because infant skin has higher permeability and surface-area-to-weight ratio and lemongrass extracts can contain absorbable volatile constituents (e.g., citral), exposure was increased by +1 for 0–3 yr (adult exposure low → infant moderate). Note: primary concern for topical use is skin sensitization (citral), not documented developmental toxicity for this extract. Sources: CosIng, PubChem, PubMed, EWG, ECHA (no harmonised classification).
- Wie bewertet VeriMom cymbopogon citratus leaf extract oxidized?
- VeriMom bewertet cymbopogon citratus leaf extract oxidized mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu cymbopogon citratus leaf extract oxidized?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu cymbopogon citratus leaf extract oxidized basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.